Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-20

FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved Somerset Therapeutics' original ANDA for a generic sacubitril/valsartan product, enabling a non-brand version of this heart-failure medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril and valsartan (sacubitril/valsartan)

Snippet

ORIG AP for SACUBITRIL AND VALSARTAN (SACUBITRIL AND VALSARTAN)